MIF and breast cancer: This anti-tumor phenotype associated with MIF-deficient 4T1 breast cancer tumors was attributed to the elicitation of significantly fewer intratumoral M-MDSCs in both the in vivo breast cancer models and in an in vitro model of M-MDSC differentiation.